OTCMKTS:WUXIF WuXi AppTec (WUXIF) Stock Forecast, Price & News $10.70 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$10.70▼$10.7050-Day Range$8.61▼$10.7052-Week Range$7.91▼$12.41VolumeN/AAverage Volume250 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesShort InterestProfileChartCompetitorsHeadlinesShort Interest About WuXi AppTec (OTCMKTS:WUXIF) StockWuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.Read More WUXIF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WUXIF Stock News HeadlinesSeptember 30, 2023 | finance.yahoo.comWUXI APPTEC H 02359 YC1 (WX8.DU)September 30, 2023 | americanbankingnews.comShort Interest in WuXi AppTec Co., Ltd. (OTCMKTS:WUXIF) Rises By 23.9%September 30, 2023 | Weiss Ratings (Ad)These cryptos could skyrocket by JanuaryAfter the massive market collapse and several huge scandals last year, a lot of experts are saying the crypto markets are just one more step away from going to zero. But are they right?September 26, 2023 | benzinga.comPDX Model Market Trends, Segmentation, Growth Factors, Opportunities, Key Players and Future OutlookAugust 22, 2023 | technews.tmcnet.comCabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201August 1, 2023 | finance.yahoo.comDNA-Encoded Libraries (DELs) and NanoBRET Target Engagement Assays Accelerate Drug DiscoveryAugust 1, 2023 | marketwatch.comWuXi AppTec Shares Rise After First-Half Earnings BeatJuly 31, 2023 | finance.yahoo.comWuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022September 30, 2023 | Weiss Ratings (Ad)These cryptos could skyrocket by JanuaryAfter the massive market collapse and several huge scandals last year, a lot of experts are saying the crypto markets are just one more step away from going to zero. But are they right?July 21, 2023 | benzinga.comPharmaceutical Contract Manufacturing Market worth $258.3 billion by 2028, at a CAGR of 7.9%July 5, 2023 | finance.yahoo.comWX8.SG - Wuxi AppTec Co LtdMay 17, 2023 | forbes.comPharma Billionaire Zhao Ning Dies At 56 After Battling Cancer For 20 YearsMay 16, 2023 | marketwatch.comDiscovery Bioanalysis Market Report Revealing The Latest Trends And Advances From 2023 to 2030| WuXi AppTec, Charles River, CovanceMay 9, 2023 | markets.businessinsider.comInterius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced TherapiesApril 26, 2023 | marketwatch.comWuXi AppTec's First-Quarter Profit SurgesApril 24, 2023 | msn.comWuXi AppTec GAAP EPS of RMB0.72, revenue of RMB8.96BApril 24, 2023 | finance.yahoo.comWuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022April 7, 2023 | marketwatch.comThe State of the Cell Banking Outsourcing Market | New Research Report (2023-2030)April 6, 2023 | marketwatch.comClinical Trial Packaging Market 2023 Size and Forecast to 2031April 3, 2023 | marketwatch.com2023-2029 In-Silico Drug Discovery Market Size (Share and Outlook) with Manufacturing Cost Structure AnalysisMarch 30, 2023 | marketwatch.comPharmaceutical CXO Market 2023 Size and Forecast to 2031March 24, 2023 | marketwatch.comDiscovery Bioanalysis Market Demand and Competitive Analysis by Key Players to 2030| WuXi AppTec, Charles River, CovanceMarch 20, 2023 | marketwatch.comGlobal Toxicology Services Market: Modest Trends and Technologies, with Demand Drivers Analysis 2023-2027March 17, 2023 | marketwatch.comPatient Derived Xenograft or PDX Models Market 2023 | Global Industry Report Forecast 2029March 16, 2023 | marketwatch.comGlobal Pharmaceutical CXO Market Size Report Analysis, 2023-2029March 15, 2023 | marketwatch.comGlobal Cell Banking Outsourcing Market (2023-2029)-Opportunities for Growth and ExpansionMarch 15, 2023 | marketwatch.comPatient-derived Xenograft (PDX) Models Market Forecast to 2023 Top Companies, Trends, Growth Factors and Detail Research for Business DevelopmentSee More Headlines Receive WUXIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:WUXIF CUSIPN/A CIKN/A Webwww.wuxiapptec.com Phone86-21-5046-1111FaxN/AEmployees41,296Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Ge Li Ph.D. (Age 56)Co-Founder, Chairman, Pres & CEO Comp: $5.75MDr. Minzhang Chen Ph.D. (Age 53)Co-CEO & Exec. Director Comp: $1.36MDr. Qing Yang Ph.D. (Age 53)Co-CEO & Exec. Director Comp: $1.17MDr. Edward Hu M.B.A. (Age 60)Vice Chairman & Global Chief Investment Officer Comp: $1.46MMr. Zhaohui Zhang (Age 53)COO of China, VP & Exec. Director Comp: $1.03MMs. Ming Shi (Age 48)Sr. VP & CFO Mr. Kyler LeiIR DirectorDr. Howard Wu J.D.Sr. VP, Gen. Counsel & Global Head of HRDr. Shuhui Chen Ph.D. (Age 59)Exec. VP & Head of DDSU Dr. Jingchao Dong Ph.D.Sr. VP & Head of RCSMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors WUXIF Stock - Frequently Asked Questions How have WUXIF shares performed in 2023? WuXi AppTec's stock was trading at $10.71 at the start of the year. Since then, WUXIF shares have decreased by 0.1% and is now trading at $10.70. View the best growth stocks for 2023 here. Are investors shorting WuXi AppTec? WuXi AppTec saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 603,600 shares, an increase of 23.9% from the August 31st total of 487,100 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 6,036.0 days. View WuXi AppTec's Short Interest. What is WuXi AppTec's stock symbol? WuXi AppTec trades on the OTCMKTS under the ticker symbol "WUXIF." How do I buy shares of WuXi AppTec? Shares of WUXIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is WuXi AppTec's stock price today? One share of WUXIF stock can currently be purchased for approximately $10.70. How many employees does WuXi AppTec have? The company employs 41,296 workers across the globe. How can I contact WuXi AppTec? WuXi AppTec's mailing address is 288 Fute Middle Road, Shanghai, 200131. The official website for the company is www.wuxiapptec.com. The company can be reached via phone at 86-21-5046-1111. This page (OTCMKTS:WUXIF) was last updated on 9/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi AppTec Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.